Breakthroughs Blog

City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.

Monica Curiel, City of Hope patient, author
Young Lymphoma Survivor Pens Children’s Book

July 12, 2017 | Samantha Bonar

Monica Curiel was 19 years old, a freshman in college, when diagnosed. Now a survivor, her book, Stella's Picture Day, for pediatric cancer patients, was published in May 2016.

Continue Reading

robert w chen md 256x256
Immunotherapy Drug Shown Safe and Effective in Treating Hodgkin Lymphoma

June 29, 2017 | Katie Neith

Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.

Continue Reading

Christine Magnus Moore
Caregiver, Cancer Survivor and Author: City of Hope Nurse Christine Magnus Moore

June 5, 2017 | Michael Easterling

As an oncology nurse, Christine Magnus Moore, R.N., B.S.N., has cared for patients going through the most challenging circumstances one can imagine. But she didn’t fully comprehend the courage of these cancer patients until she became one herself.

Continue Reading

Mark Paolera
Immunotherapy Gives Hodgkin Lymphoma Patient a Second Chance

May 26, 2017 | Samantha Bonar

Four years ago, Mark Paolera, now 39, was busy enjoying the typical active California lifestyle, including mountain biking, hiking and deep-sea fishing. After a battery of tests, Paolera was diagnosed with Stage 2 Hodgkin lymphoma in May of 2014.

Continue Reading

Chen-Robert
Trial Results Point to Promising Treatments for Hodgkin Lymphoma Patients

January 9, 2017 | Abe Rosenberg

Everything changed when Hodgkin lymphoma patient Lowell Winer joined a Phase II clinical trial examining the effectiveness of brentuximab vedotin (BV) after a failed transplant. The BV worked immediately, achieving a complete remission which, year after year, proved to be durable beyond anyone's expectations.

Continue Reading

breakthroughs - Commander Ann Clark
Hodgkin lymphoma survivor and LAPD Commander to ride 2017 City of Hope Rose Parade float

December 17, 2016 | Letisia Marquez

For the 45th year in a row, City of Hope will participate in the Tournament of Roses Parade. This year, seven patients will welcome 2017 atop City of Hope’s Rose Parade float. Meet Hodgkin lymphoma survivor Commander Ann Clark.

Continue Reading

breakthroughs - darrell george
2017 Rose Parade: 6 questions for non-Hodgkin lymphoma survivor Darrell George

December 5, 2016 | Denise Heady

For the 45th year in a row, City of Hope will participate in the Tournament of Roses Parade. This year, seven patients will welcome 2017 atop City of Hope’s Rose Parade float. Meet non-Hodgkin lymphoma survivor Darrell George.

Continue Reading

Chen-Robert
When Hodgkin Lymphoma returns, a new drug may offer hope

August 16, 2016 | Letisia Marquez

Patients whose Hodgkin lymphoma has returned after a stem cell transplant have few treatment options available but a new drug tested at City of Hope may change that. ABC-7 in Los Angeles featured research by Robert Chen, M.D., on the use of the new medication – brentuximab vedotin (BV) – by these patients.

Continue Reading

Chen-Robert
Research suggests brentuximab vedotin potentially curative in some Hodgkin lymphoma patients with limited treatment options

July 18, 2016 | City of Hope

Study, published in Blood, reports on five-year survival data, suggests targeted therapy should be standard of care for patients with relapsed or treatment-resistant Hodgkin lymphoma.

Continue Reading

Load More
Back To Top